In a recent Phase III multi-trial project, a large pharmaceutical
company approached Medpace to manage four large type 2 diabetes
trials concurrently. The trials were pivotal studies that needed to run
aggressively so the pharmaceutical company could file their New
Drug Application (NDA) by the targeted submission date. Medpace’s
therapeutically focused, specialized diabetes project teams were
quickly mobilized to start the trials simultaneously. The Medpace
teams initiated, coordinated, and oversaw all trial activities from
project start-up to project completion, tracking metrics and providing
a full range of services to the Sponsor.